Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

The 13-valent pneumococcal conjugate vaccine (PCV13) is the only licensed PCV with serotype 3 polysaccharide in its formulation. Postlicensure PCV13 effectiveness studies against serotype 3 invasive pneumococcal disease (IPD) in children have shown inconsistent results.  We performed a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sings, Heather L, De Wals, Philippe, Gessner, Bradford D, Isturiz, Raul, Laferriere, Craig, McLaughlin, John M, Pelton, Stephen, Schmitt, Heinz-Josef, Suaya, Jose A, Jodar, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541704/
https://www.ncbi.nlm.nih.gov/pubmed/30357326
http://dx.doi.org/10.1093/cid/ciy920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541704/
https://www.ncbi.nlm.nih.gov/pubmed/30357326
http://dx.doi.org/10.1093/cid/ciy920

Ejemplares similares